A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer

Liu, Y., Wu, Z., Zhou, J., Ramadurai, D. K. A., Mortenson, K. L., Aguilera-Jimenez, E., Yan, Y., Yang, X., Taylor, A. M., Varley, K. E., Gertz, J., Choi, P. S., Cherniack, A. D., Chen, X., Bass, A. J., Bailey, S. D., & Zhang, X. (2021). A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-27055-4
Authors:
Yanli Liu
Zhong Wu
Jin Zhou
Dinesh K A Ramadurai
Katelyn L Mortenson
Estrella Aguilera-Jimenez
Yifei Yan
Xiaojun Yang
Alison M Taylor
Katherine E Varley
Jason Gertz
Peter S Choi
Andrew D Cherniack
Xingdong Chen
Adam J Bass
Swneke D Bailey
Xiaoyang Zhang
Affiliated Authors:
Alison M Taylor
Adam J Bass
Publication Type:
Article
Unique ID:
10.1038/s41467-021-27055-4
PMID:
Publication Date:
Data Source:
PubMed

Record Created: